Q&A: H1N1 pandemic influenza - what's new?

BMC Biology

Volumn 8, Issue , 2010, Pages

  Turner, Stephen J ^a   Doherty, Peter C ^a,b   Kelso, Anne ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANTIGENIC VARIATION; ARTICLE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; GENETICS; HISTORY; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MUTATION; PANDEMIC; TREATMENT OUTCOME;

ANTIGENIC VARIATION; DISEASE SUSCEPTIBILITY; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MUTATION; PANDEMICS; TREATMENT OUTCOME; VIRAL VACCINES;

EID: 77957808687     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-8-130     Document Type: Note

References (24)

1. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719. 10.1056/NEJMra1000449, 20445182, Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza.
2. Pasma T, Joseph T. Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg Infect Dis 2010, 16:706-708.
3. Vijaykrishna D, Poon LL, Zhu HC, Ma SK, Li OT, Cheung CL, Smith GJ, Peiris JS, Guan Y. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010, 328:1529. 10.1126/science.1189132, 20558710.
4. Turner SJ, Brown LE, Doherty PC, Kelso A. Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?. J Biol 2009, 8:69. 2656218, 19222865, 10.1186/jbiol179.
5. Octaviani CP, Ozawa M, Yamada S, Goto H, Kawaoka Y. High genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol 2010,
6. (CDC) CFD, et al. Update: influenza activity - United States, 2009-10 season. MMWR Morb Mort Wkly Rep 2010, 59:901-908.
7. Updated CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 - April 10, 2010. , http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm
8. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 2010, 328:357-360. 10.1126/science.1186430, 20339031.
9. Skountzou I, Koutsonanos DG, Kim JH, Powers R, Satyabhama L, Masseoud F, Weldon WC, Martin Mdel P, Mittler RS, Compans R, Jacob J. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010, 185:1642-1649. 10.4049/jimmunol.1000091, 20585035.
10. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R, Ponomarenko J, Scheuermann RH, Sette A, Peters B. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009, 106:20365-20370. 2777968, 19918065, 10.1073/pnas.0911580106.
11. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G, Chan PL, Lam KT, Guan J, Zhang L, Guan Y, Yuen KY, Peiris JS, Lau YL. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 84:6527-6535. 10.1128/JVI.00519-10, 20410263.
12. Gras S, Kedzierski L, Valkenburg SA, Laurie K, Liu YC, Denholm JT, Richards MJ, Rimmelzwaan GF, Kelso A, Doherty PC, Turner SJ, Rossjohn J, Kedzierska K. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 2010, 107:12599-12604. 10.1073/pnas.1007270107, 20616031.
13. Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008, 118:3478-3490. 2542885, 18802496.
14. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293:1840-1842. 10.1126/science.1062882, 11546875.
15. Herfst S, Chutinimitkul S, Ye J, de Wit E, Munster VJ, Schrauwen EJ, Bestebroer TM, Jonges M, Meijer A, Koopmans M, Rimmelzwaan GF, Osterhaus AD, Perez DR, Fouchier RA. Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 2010, 84:3752-3758. 2849492, 20130063, 10.1128/JVI.02634-09.
16. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010, 84:8607-8616. 10.1128/JVI.00159-10, 20592084.
17. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010, 328:1272-1275. 10.1126/science.1187816, 20522774.
18. Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, Webby RJ, Webster RG, Govorkova EA. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog 2010, 6:e1001022. 2912389, 20686654, 10.1371/journal.ppat.1001022.
19. Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, García-Sastre A, Staeheli P, Palese P. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol 2010, 84:11219-11226.
20. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, Nissen M, Marshall H, Booy R, Heron L, Hartel G, Lai M, Basser R, Gittleson C, Greenberg M. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303:37-46. 10.1001/jama.2009.1911, 20026597.
21. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326:729-733. 2880578, 19745114, 10.1126/science.1177373.
22. Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-1064. 10.1126/science.1192517, 20647428.
23. Steel J, Lowen AC, Wang T, Yondola M, Gao Q, Haye K, Garcia-Sastre A, Palese P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010, 1(pii):e00018-10. 2912658, 20689752.
24. DeFranco AL, Locksley RM, Robertson M. Immunity: The immune response in infectious and inflammatory disease 2007, Oxford University Press.